Evidence map›Paper›PMID 32383509›Full record

ArticleAnaesthesia2020

10 kHz spinal cord stimulation for the treatment of non-surgical refractory back pain: subanalysis of pooled data from two prospective studies.

A Al-Kaisy, J P Van Buyten, L Kapural, K Amirdelfan, B Gliner, D Caraway, J Subbaroyan, D Edgar, A Rotte

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Anaesthesia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Pain, quality of life, and function in chronic intractable leg pain were substantially improved with 10kHz spinal cord stimulation in a multicentre European study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Observational
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Advances in Spinal Cord Stimulation.Bioengineering (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

A Al-KaisyThe Pain Management and Neuromodulation Centre, Guy's and St. Thomas' Hospital, London, UK.
J P Van BuytenMultidisciplinary Pain Centre, AZ Nikolaas, St Niklaas, Belgium.
L KapuralCarolina's Pain Institute, Winston-Salem, NC, USA.
K AmirdelfanIPM Medical Group, Inc., Walnut Creek, CA, USA.
B GlinerClinical and Regulatory Affairs, Nevro Corp.
D CarawayClinical and Regulatory Affairs, Nevro Corp.
J SubbaroyanClinical and Regulatory Affairs, Nevro Corp.
D EdgarCommexus Ltd., Dunblane, UK.
A RotteClinical and Regulatory Affairs, Nevro Corp.
Nevro (United States) · USCarolinas Pain Institute · USFlex (Mauritius) · MUKaiser Permanente Walnut Creek Medical Center · USSt Thomas' Hospital · GBVlaamse Vereniging voor Obstetrie en Gynaecolo · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord stimulation at 10 kHz is a promising therapy for non-surgical refractory back pain; however, published data are currently limited. We present a subanalysis of prospectively collected clinical outcome data for non-surgical refractory back pain patients treated with 10 kHz spinal cord stimulation, from the independent cohorts of two previous studies (SENZA-RCT and SENZA-EU). Clinical outcomes were evaluated at pre-implantation (baseline), 3 months, 6 months and 12 months following 10 kHz spinal cord stimulator implantation. These included: pain relief; responder rate (≥ 50% pain relief from baseline); remission rate (VAS ≤ 3.0 cm); disability (Oswestry Disability Index(ODI)); and opioid use. At 3 months, average back pain decreased by 70% in the combined cohort (60% in the SENZA-RCT and 78% in the SENZA-EU cohorts). This was sustained at 12 months, with a 73% back pain responder rate and 68% remission rate in the combined cohort. Leg pain relief results were generally comparable to those for back pain relief. At 12 months, the combined cohort had an average decrease in ODI scores of 15.7% points from baseline and opioid use more than halved. In conclusion, 10 kHz spinal cord stimulation reduced pain, disability and opioid consumption in non-surgical refractory back pain subjects. Application of this therapy may improve the care of non-surgical refractory back pain patients and reduce their opioid consumption.

Indexed as

Back PainChronic PainFemaleHumansMaleMiddle AgedPain ManagementPain MeasurementProspective StudiesSpinal Cord StimulationTreatment Outcome10 kHz SCSaxial back painchronic painmaiden back painnon-specific low back painnon-surgical back painopioidsVASvirgin back pain

Identifiers

PMID32383509
PMCPMC7384077
OpenAlexW3023847784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.